Eurofins Scientific SE (XPAR:ERF) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ERF Eurofins Scientific SE XPAR:ERF
86 GF Score
Price €69.50
GF Value €67.12
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Eurofins Scientific SE Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Eurofins Scientific SE Valuation Rank Related Terms

XPAR:ERF
86GF Score
Eurofins Scientific SE XPAR:ERF
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eurofins Scientific SE (XPAR:ERF) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of €69.50 is trading 3.5% above its estimated GF Value™ of €67.12. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for XPAR:ERF:

  • Valuation Rank:
  • GF Value™: €67.12 vs. price of €69.50 (3.5% above fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the XPAR:ERF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
86GF Score

Get the complete analysis for XPAR:ERF

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.50
Price
€67.12
GF Value